A detailed history of Virtu Financial LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 22,255 shares of ABOS stock, worth $41,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,255
Previous 24,402 8.8%
Holding current value
$41,171
Previous $59,000 6.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$2.22 - $3.54 $4,766 - $7,600
-2,147 Reduced 8.8%
22,255 $55,000
Q2 2024

Aug 09, 2024

BUY
$2.14 - $4.01 $52,220 - $97,852
24,402 New
24,402 $59,000
Q4 2023

Feb 26, 2024

BUY
$1.86 - $4.48 $44,243 - $106,565
23,787 New
23,787 $91,000
Q2 2022

Aug 09, 2022

BUY
$3.08 - $4.88 $80,708 - $127,875
26,204 New
26,204 $123,000

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $74.9M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.